Avon launches first wrinkle buster that works on 100% of women!

London: Avon is launching a new anti-wrinkle formula that not only prevents collagen breakdown – the main reason for wrinkle formation –  but also reverses skin damage including fine lines and wrinkles, in 100% of women who tested it.

The company claims that no other test on any other wrinkle cream currently on the market has produced such positive results. And that the new formula has proven in tests on real woman it works better than any other now on sale in the market – including those containing all the currently scientifically proven collagen boosters such as Alpha Hydroxy Acids, retinol (Vitamin A), vitamin C and skin growth factors.
Avon Anew A-F33 small.png
Now thousands of women  – 30,000 in the UK alone –  are going online to sign up for the chance to be offered a 28-day free trial of the cream which goes on sale in the UK in September.
The new ingredient is a lab-made amino acid derivative, known as A-F33 which effectively boosts production of a skin enzyme – PLOD2 – which in turn leads to increased collagen production in the skin. The company says that 100% of woman using the cream had improvements in wrinkle depth – including deep wrinkles caused by smoking and sun damage.
Avon has added A-F33 to create the new product – an addition to the ANEW cutting-edge anti-ageing range to create Pro Line Creating Treatment which will sell at £30 for 30ml when it goes on sale through its Avon ‘ladies’ network.
The new product has been brought to market through an alliance with NeoStrata Company, a global leader in topical anti-aging technologies, whose products are sold through private dermatologists and medical practices.
According to the Avon press release: ” ANEW Clinical Pro Line Corrector Treatment leverages the power of A-F33 Aminofill, an innovative molecule that has been found in testing on skin cells to work in a way that other well-known anti-aging ingredients like glycolic acid, retinol, and CoQ10 don’t by deactivating critical collagen blocking in skin cells to help unleash untapped collagen. A-F33 is formulated to help stimulate skin cells to produce skin matrix components.  ANEW Clinical Pro Line Corrector Treatment helps begin to reduce the look of deep and fine wrinkles in just seven days.” 
Scientists tested the product against a rival product – the company insists it won’t name this product but we can exclusively reveal it was Clinique’s Repairwear Laser Focus Wrinkle & UV Damage Corrector serum (££39.50 for 30ml).  The results on real women aged between 35 and 59 years showed that it was 40% more effective at reducing wrinkle depth.  Avon also claims that in many cases the results were even better but they have picked the average change – many of the woman had a 94% decrease in fine lines and wrinkles over the 3 months of the lab trial.
Screen shot 2012-07-12 at 12.35.06.png
Avon’s senior research & development scientist Anthony Gonzalez unveiling the product in London yesterday said they were considering its use in other formulations, including body products.  It has also been successful in evening out skin tone and other discolourations caused by ageing and sun damage.
“It’s unknown for a product to have a reduction in fine wrinkles in100% of women,” he said.
deepwrinkle success small.png
If you would like the chance to try out this serum please contact us at readeroffer@elixirnews.com
Enhanced by Zemanta

Actress Jacqueline Bisset is the new face of Avon ANEW Platinum

New York: Avon Products, Inc. today announced a partnership with award-winning international actress, Jacqueline Bisset, who will serve as the face of the anti-ageing skincare line ANEW Platinum.

Bisset [320x200].jpgThis new skincare line for women 60+ from Avon’s pioneering ANEW line was developed to recapture the appearance of youthful contours and will debut this fall through Avon reps.

“I am excited to be working with Avon on the ANEW Platinum Collection, as it specifically addresses the needs of women with my skincare concerns,” said Jacqueline.


“I want a skincare product that makes my skin look as young as I feel. ANEW Platinum helps recapture the definition and tone of younger skin.”

“Jacqueline embodies everything the ANEW woman aspires to be– beauty, poise and sophistication,” says Andre Baradat, Vice President, Global Skincare Marketing, Avon. “We are thrilled to have such an amazing international beauty icon as the face of our new breakthrough ANEW Platinum line.”

The ANEW Platinum Night Cream and Serum goes on sale in November and launched in an advertising campaign featuring Jacqueline Bisset. She will also appear in the pages of the Avon brochure for ANEW Platinum.

ANEW, the pioneering anti-aging line from Avon, delivers transformative anti-aging skincare to millions of women throughout the world. With almost 2400 jars an hour¹, the line has been helping women visibly outsmart the aging process from the brand’s inception in 1992.

Bisset is the most recent star to join Avon’s roster of celebrity partners, including Fergie, Courteney Cox, Patrick Dempsey, Salma Hayek, Reese Witherspoon and Derek Jeter.

Find out morea bout Avon ANEW in this video

About Jacqueline Bisset
Serving as the spokesperson for ANEW Platinum, actress Jacqueline Bisset has brought her stunning looks and tremendous talent to over 50 films. Born in Weybridge, England, the highly regarded actress has garnered prestigious awards throughout the world.

About Avon Products, Inc.
Avon, is a leading global beauty company, with over $10 billion in annual revenue. As the world’s largest direct seller, Avon markets to women in more than 100 countries through 6.2 million independent Avon Sales Representatives. Avon’s product line includes beauty products, as well as fashion and home products, and features such well-recognized brand names as Avon Color, ANEW, Skin-So-Soft, Advance Techniques, Avon Naturals, and mark. Learn more about Avon and its products at www.avoncompany.com.

Avon growth falls – 1 August 2006

Avon Products has announced a significant drop in its profits as restructuring charges hit the bottom line and the company’s performance in most markets, including the US, came in below expectations.

The company said that during its second quarter, net income dropped 54 per cent to reach $150.9m on the back $2.1bn in sales, up 5 per cent on the same period last year.

The company said that it incurred a $49m charge, as part of its massive restructuring programme, introduced in the last quarter of 2005. These costs included organisational realignments and a reduction in the workforce, particularly in its middle management.

Avon CEO Andrea Jung said that the company has now eliminated more than 25 per cent of its management positions and lowered the number of management tiers from 15 to eight. This means that to date the company has eliminated 10 per cent of its 43,000 workforce worldwide.

Analysts had expected the drop in profits, but the performance was not as good as average forecasts had expected.

Morgan Stanley said that there could be a limited amount of negative reaction on the stock markets in response to weak top line growth in all markets except China.

The North American market remains flat, although that reverses the steady decline in sales experienced last year. The company said that sales volume were down by 5 per cent, in conjunction with a 7 per cent decline in sales representatives that the company said was exacerbated by rising fuel costs.

Although sales were up by 2 per cent in Europe as a whole, many of the established markets have proved to be tough in the face of stiff competition. The exception has been Turkey, which had proved to be a strong performer on the back of good retail conditions.

In the Central and Eastern European region sales were up 4 per cent, representing a decrease in volumes. The company said that this was due to a fall in colour cosmetic sales throughout the Central European market.

This performance was boosted by stronger results in Russia, which helped to offset a poorer performance in Poland.

Outside of Europe, Asia was particularly disappointing, with sales down 10 per cent, mainly caused by a down-turn in the Japanese market.

In Asia the one shining light proved to be the China market, where sales grew by 8 per cent, in line with expectations. The company said that this figure came about from the resumption of direct sales at the beginning of this year.

In Latin America sales were up 17 per cent, boosted by last year’s acquisition in the Colombia market and the continued growth of the Brazilian market. However, the company said that the Mexico market had proved to be ‘soft’ contributing to lower underlying growth.

Avon’s restructuring scheme aims to save the company around $100m a year, but will have to be fed by top line growth that, judging by the last quarter’s result, is not happening.

In the longer-term results will almost certainly be cushioned by significant savings, but top line growth will have to resume if the company is to sustain the estimated $500m total restructuring costs.